Investigator choice of standard therapy versus sequential novel therapy arms in the treatment of relapsed follicular lymphoma (REFRACT): study protocol for a multi-centre, open-label, randomised, phase II platform trial.
Saved in:
| Title: | Investigator choice of standard therapy versus sequential novel therapy arms in the treatment of relapsed follicular lymphoma (REFRACT): study protocol for a multi-centre, open-label, randomised, phase II platform trial. |
|---|---|
| Authors: | McIlroy, Graham1 (AUTHOR) g.w.mcilroy.1@bham.ac.uk, Lax, Siân1 (AUTHOR), Gaskell, Charlotte1 (AUTHOR), Jackson, Aimee1 (AUTHOR), Rhodes, Malcolm2 (AUTHOR), Seale, Tania3 (AUTHOR), Fox, Sonia1 (AUTHOR), Hopkins, Lousie1 (AUTHOR), Okosun, Jessica4 (AUTHOR), Barrington, Sally F.5 (AUTHOR), Ringshausen, Ingo6 (AUTHOR), Ramsay, Alan G.7 (AUTHOR), Calaminici, Maria8 (AUTHOR), Linton, Kim3,9 (AUTHOR), Bishton, Mark10,11 (AUTHOR) |
| Source: | BMC Cancer. 3/25/2024, Vol. 24 Issue 1, p1-13. 13p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 14712407 |
|---|---|
| DOI: | 10.1186/s12885-024-12112-0 |
